1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Quince Therapeutics, Inc.

Quince Therapeutics, Inc.

QNCX
Quince Therapeutics, Inc.US flagNASDAQ Global Select
18.22
USD
-0.56
- -
5.07MMarket Cap

Income Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
10
12
39
79
90
51
27
36
50
+ Selling, General & Admin
1
2
9
18
30
26
18
18
15
+ Research & Development
9
10
30
61
61
25
9
19
35
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-10
-12
-39
-79
-90
-51
-27
-36
-50
- Non-Operating (Income) Loss
2
- -
-2
-2
- -
1
4
21
30
+ Interest Expense, Net
2
- -
-2
-2
-1
-1
-3
-3
-1
+ Interest Expense
2
1
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
1
2
2
1
1
3
3
1
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
2
8
24
32
Pretax Income
-12
-12
-37
-77
-90
-52
-32
-57
-81
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
3
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-12
-12
-37
-77
-90
-52
-31
-57
-84
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-12
-12
-37
-77
-90
-52
-31
-57
-84
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-12
-12
-37
-77
-90
-52
-31
-57
-84
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-12
-12
-37
-77
-90
-52
-31
-57
-84
EBIT
-10
-12
-39
-79
-90
-51
-27
-36
-50
EBITDA
-10
-12
-39
-79
-90
-51
-27
-36
-50
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
-10
-12
-39
-79
-90
-51
-27
-36
-50
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-113.54
-115.78
-388
-526.79
-605.32
-308.45
-168.57
-262.71
-335.27
Basic EPS from Cont Ops
-113.54
-115.78
-388
-526.79
-605.32
-308.45
-168.57
-262.71
-335.27
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
Diluted EPS, GAAP
-113.54
-115.78
-388
-526.79
-605.32
-308.45
-168.57
-262.71
-335.27
Diluted EPS from Cont Ops
-113.54
-115.78
-388
-526.79
-605.32
-308.45
-168.57
-262.71
-335.27

Balance Sheet (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
8
73
106
138
112
94
77
44
23
+ Cash, Cash Equivalents & STI
7
72
100
134
107
90
75
41
18
+ Cash & Cash Equivalents
7
25
51
67
70
45
21
6
6
+ ST Investments
- -
47
49
67
37
46
54
35
12
+ Accounts & Notes Receiv
- -
- -
- -
- -
1
1
1
1
4
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
1
1
1
1
4
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
6
4
4
3
1
2
2
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
18
52
22
10
90
70
71
+ Property, Plant & Equip, Net
- -
- -
1
1
1
1
1
1
1
+ Property, Plant & Equip
- -
- -
2
2
2
1
1
1
2
- Accumulated Depreciation
- -
- -
- -
1
1
- -
1
1
1
+ LT Investments & Receivables
- -
- -
17
50
20
4
- -
- -
- -
+ LT Investments
- -
- -
17
50
20
4
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
6
90
70
70
+ Total Intangible Assets
- -
- -
- -
- -
- -
6
81
60
68
+ Goodwill
- -
- -
- -
- -
- -
- -
18
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
6
64
60
68
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
8
10
2
Total Assets
8
73
124
189
133
104
168
114
94
+ Payables & Accruals
2
1
9
17
13
2
5
7
13
+ Accounts Payable
1
- -
3
4
5
1
2
3
2
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
1
6
13
8
2
3
4
10
+ ST Debt
- -
- -
- -
- -
1
- -
- -
- -
18
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
18
+ ST Finance Leases
- -
- -
- -
- -
1
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
- -
- -
4
- -
13
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
4
- -
13
Total Current Liabilities
2
1
9
17
14
3
10
7
43
+ LT Debt
7
- -
- -
- -
- -
- -
14
15
- -
+ LT Borrowings
7
- -
- -
- -
- -
- -
13
14
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
19
104
- -
- -
- -
- -
59
62
86
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
5
5
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
19
104
- -
- -
- -
- -
54
57
86
Total Noncurrent Liabilities
26
104
- -
- -
- -
- -
73
77
86
Total Liabilities
28
106
9
17
15
3
83
84
129
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
185
319
355
389
402
407
419
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
185
319
355
389
402
407
419
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-20
-33
-70
-147
-237
-288
-320
-376
-460
+ Other Equity
- -
- -
- -
- -
- -
- -
3
- -
6
Equity Before Minority Interest
-20
-33
115
172
119
101
85
30
-36
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-20
-33
115
172
119
101
85
30
-36
Total Liabilities & Equity
8
73
124
189
133
104
168
114
94
Shares Outstanding
- -
- -
- -
- -
- -
- -
- -
- -
- -
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
1
- -
- -
- -
- -
Net Debt
- -
-25
-51
-67
-70
-45
-7
8
12
Net Debt to Equity
0.85
76.23
-44.35
-38.8
-58.8
-44.32
-8.61
26.9
-34.21
Tangible Common Equity Ratio
-262.76
-44.77
92.85
90.92
89.01
96.62
4.37
-54.93
-402.79
Current Ratio
4.28
49.82
11.93
8.11
7.85
30.55
8.09
6.05
0.53
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-12
-12
-37
-77
-90
-52
-31
-57
-84
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
2
1
2
15
31
17
11
25
30
+ Stock-Based Compensation
- -
- -
2
14
30
17
5
5
5
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
-5
+ Asset Impairment Charge
- -
- -
- -
- -
- -
1
6
17
- -
+ Other Non-Cash Adj
2
1
- -
1
1
- -
- -
3
29
+ Chg in Non-Cash Work Cap
- -
- -
2
10
-4
-10
2
- -
13
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-5
2
-1
3
4
-2
3
+ Inc (Dec) in Accts Payable
- -
- -
7
8
-3
-13
-2
2
5
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
-1
5
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-10
-12
-33
-51
-63
-44
-18
-32
-41
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
78
118
- -
1
- -
- -
18
+ Increase in Capital Stock
- -
- -
78
118
- -
1
- -
- -
18
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
-47
-18
-52
59
7
-3
22
24
+ Dec in LT Investment
- -
9
118
135
98
82
111
112
58
+ Inc in LT Investment
- -
-55
-135
-187
-39
-75
-114
-90
-34
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
11
-2
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
11
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
-2
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
-1
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-47
-18
-52
59
18
-6
22
23
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
8
- -
-1
- -
- -
- -
- -
- -
- -
+ Cash From Debt
8
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
-1
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
76
- -
1
7
- -
- -
-5
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
8
76
77
119
7
1
- -
-5
18
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-2
17
26
16
3
-25
-24
-15
- -
EBITDA
-10
-12
-39
-79
-90
-51
-27
-36
-50
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-10
-12
-33
-51
-63
-44
-18
-32
-42
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
-11
2
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-12
-34
-51
-63
-44
-18
-32
-42
Free Cash Flow per Basic Share
-91.91
-110.5
-349.73
-348.71
-424.73
-263.74
-99.11
-148.68
-166.79
Price/Free Cash Flow
- -
- -
-32.21
-15.97
-5.98
-0.49
-2.16
-2.56
-4.09
Cash Flow to Net Income
0.8
0.94
0.9
0.66
0.7
0.85
0.58
0.56
0.49
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -
- -